Protein profile

PA4201

D-alanine--D-alanine ligase

Genome: NC_002516.2

Gene: PA4201 ddlA Structure source: Experimental + AlphaFold UniProt Q9HWI0
Amino acids 346
Annotations 9
Features 24
PDB binders 5
Druggability 0.559

Overview

Basic information about this protein and its source genome.

Accession
PA4201
Gene
PA4201 ddlA
Status
annotated
Amino acids
346
Structure source
Experimental + AlphaFold

Target profile

Computed evidence for target prioritization.

Human off-target
No hit
Gut microbiome off-target
hit
Essential (DEG)
Y
Localization
Cytoplasmic

Selected Druggability evidence

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.559
Structure
Pocket

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

1 EC 8 GO

Enzyme Commission (EC)

1

Gene Ontology (GO)

8
  • GO:0005829 The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
  • GO:0005524 Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
  • GO:0008716 Catalysis of the reaction: 2 D-alanine + ATP = D-alanyl-D-alanine + ADP + 2 H+ + phosphate.
  • GO:0046872 Binding to a metal ion.
  • GO:0071555 A process that results in the assembly, arrangement of constituent parts, or disassembly of the cell wall, the rigid or semi-rigid envelope lying outside the cell membrane of plant, fungal and most prokaryotic cells, maintaining their shape and protecting them from osmotic lysis.
  • GO:0009252 The chemical reactions and pathways resulting in the formation of peptidoglycans, any of a class of glycoconjugates found in bacterial cell walls and consisting of long glycan strands of alternating residues of beta-(1,4) linked N-acetylglucosamine and N-acetylmuramic acid, cross-linked by short peptides.
  • GO:0008360 Any process that modulates the surface configuration of a cell.
  • GO:0005737 The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

Sequence Features

Domain/signature hits from InterPro and related databases.

24 records
Show feature table
Start End DB Term Name
6 335 Hamap MF_00047 D-alanine--D-alanine ligase [ddl].
6 335 InterPro IPR005905 D-alanine--D-alanine ligase
133 334 SUPERFAMILY SSF56059 Glutathione synthetase ATP-binding domain-like
3 122 Gene3D G3DSA:3.40.50.20 -
5 132 SUPERFAMILY SSF52440 PreATP-grasp domain
5 132 InterPro IPR016185 Pre-ATP-grasp domain superfamily
100 111 ProSitePatterns PS00843 D-alanine--D-alanine ligase signature 1.
100 111 InterPro IPR000291 D-alanine--D-alanine ligase/VANA/B/C, conserved site
7 123 Pfam PF01820 D-ala D-ala ligase N-terminus
7 123 InterPro IPR011127 D-alanine--D-alanine ligase, N-terminal domain
138 332 ProSiteProfiles PS50975 ATP-grasp fold profile.
138 332 InterPro IPR011761 ATP-grasp fold
123 330 Gene3D G3DSA:3.30.470.20 -
147 330 Pfam PF07478 D-ala D-ala ligase C-terminus
147 330 InterPro IPR011095 D-alanine--D-alanine ligase, C-terminal
7 331 NCBIfam TIGR01205 D-alanine--D-alanine ligase
7 331 InterPro IPR005905 D-alanine--D-alanine ligase
148 211 Gene3D G3DSA:3.30.1490.20 -
148 211 InterPro IPR013815 ATP-grasp fold, subdomain 1
4 344 PANTHER PTHR23132 D-ALANINE--D-ALANINE LIGASE
277 305 ProSitePatterns PS00844 D-alanine--D-alanine ligase signature 2.
277 305 InterPro IPR000291 D-alanine--D-alanine ligase/VANA/B/C, conserved site
3 343 PIRSF PIRSF039102 Ddl/VanB
3 343 InterPro IPR005905 D-alanine--D-alanine ligase

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

3 + 1

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
PDB 8EVW
X-ray 1.22 Å A,B
100.0% 1-346
Viewing
PDB 8EVX
X-ray 1.55 Å A,B
100.0% 1-346
Loaded
PDB 8EVV
X-ray 2.05 Å A,B,C,D
100.0% 1-346
Loaded
AlphaFold PA4201
AlphaFold full sequence Loaded
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
1 0.559

Pockets (P2RANK)

Showing top-ranked P2Rank candidates by probability. Probability is color-coded per P2Rank calibration: high (≥ 0.5), medium (0.2 – 0.49), low (< 0.2).

P2RANK Sticks Spheres Surfaces Score Probability Labels Zoom Positions
1 40.12 0.963
2 7.2 0.375
3 1.62 0.026
4 1.55 0.023
5 1.51 0.022

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

55 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
ANP Q5HEB7 506.2 Da LogP -2.06 TPSA 281.9 3 viol. ✓ Clean c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)…
DS0 P07862 182.1 Da LogP -1.23 TPSA 114.4 ✓ Ro5 ✓ Clean C1[C@H](C(=NO1)OP(=O)(O)O)N
G1L Q5HEB7 279.7 Da LogP 3.91 TPSA 29.1 ✓ Ro5 ✓ Clean CC(C)(CCl)C(=O)Nc1ccc(cc1)C(F)(F)F
PHY P07862 275.1 Da LogP 0.40 TPSA 147.2 ✓ Ro5 ✓ Clean C[C@@H](C[P@](=O)([C@@H](C)N)OP(=O)(O)O)C(=O)O
POB P07862 291.1 Da LogP 0.47 TPSA 156.4 ✓ Ro5 ✓ Clean CC[C@H](C(=O)O)O[P@](=O)([C@@H](C)N)OP(=O)(O)O

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.